209 related articles for article (PubMed ID: 6959129)
1. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.
Poirier MC; Lippard SJ; Zwelling LA; Ushay HM; Kerrigan D; Thill CC; Santella RM; Grunberger D; Yuspa SH
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6443-7. PubMed ID: 6959129
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
Terheggen PM; Floot BG; Lempers EL; van Tellingen O; Begg AC; den Engelse L
Cancer Chemother Pharmacol; 1991; 28(3):185-91. PubMed ID: 1855275
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist WI; Lippard SJ; Stollar BD
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
Reed E; Gupta-Burt S; Litterst CL; Poirier MC
Carcinogenesis; 1990 Dec; 11(12):2117-21. PubMed ID: 1979937
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.
Fichtinger-Schepman AM; Baan RA; Luiten-Schuite A; van Dijk M; Lohman PH
Chem Biol Interact; 1985 Nov; 55(3):275-88. PubMed ID: 4075437
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments.
Brabec V; Vrana O; Kiseleva VI; Poverenny AM
Eur J Biochem; 1991 Nov; 201(3):723-30. PubMed ID: 1935966
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
[TBL] [Abstract][Full Text] [Related]
8. Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies.
Sundquist WI; Lippard SJ; Stollar BD
Biochemistry; 1986 Apr; 25(7):1520-4. PubMed ID: 3707890
[TBL] [Abstract][Full Text] [Related]
9. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
[TBL] [Abstract][Full Text] [Related]
10. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
[TBL] [Abstract][Full Text] [Related]
11. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA.
Blommaert FA; Floot BG; van Dijk-Knijnenburg HC; Berends F; Baan RA; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
Chem Biol Interact; 1998 Jan; 108(3):209-25. PubMed ID: 9528691
[TBL] [Abstract][Full Text] [Related]
12. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Olinski R; Briggs RC
Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
Swinnen LJ; Fisher SG; Erickson LC
Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
15. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment.
Ducore JM
Biochem Pharmacol; 1986 Feb; 35(4):607-11. PubMed ID: 3947390
[TBL] [Abstract][Full Text] [Related]
16. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
Waud WR
Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
[TBL] [Abstract][Full Text] [Related]
17. Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.
Vrána O; Kiseleva VI; Poverenny AM; Brabec V
Eur J Pharmacol; 1992 May; 226(1):5-13. PubMed ID: 1397055
[TBL] [Abstract][Full Text] [Related]
18. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
19. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.
Strandberg MC; Bresnick E; Eastman A
Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.
Poirier MC; Reed E; Zwelling LA; Ozols RF; Litterst CL; Yuspa SH
Environ Health Perspect; 1985 Oct; 62():89-94. PubMed ID: 4085451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
